FTC

Industry analysts are skeptical that Federal Trade Commission Chair Lina Khan can win her first fight against a drug industry merger. It will be reviewed by a judge appointed by President Donald Trump.

The president has directed the FTC to carefully consider health industry mergers that may stymie competition and drive up prices.

According to authorities, a huge surge in fraud cases targeting seniors and other vulnerable populations affected by the pandemic has been reported.

Former Orlando Health patients may have to help repay the Centers for Medicare and Medicaid Services after a federal audit discovered the hospital…

The Federal Trade Commission announced Wednesday that it will approve the sale of the troubled Naples-based hospital chain Health Management Associates if…

Scam artists are using the public’s confusion over the Affordable Care Act to obtain information and sell phony products through phone and mail, McClatchy…

The ruling may end the era of what are also called "reverse-payment" deals, in which the maker of a brand-name drug pays a maker of generic drugs to not produce a lower-priced version of their product. The Federal Trade Commission can challenge such deals in court, the justices say.